All lobbying filings

KING & SPALDING LLP

Lobbying for KANEKA PHARMA AMERICA, LLC · Distributor of life science systems

Filing 4th Quarter - Termination

Reporting period

4th Quarter 2025

Oct 1 - Dec 31 · Posted Jan 19, 2026

Income

$40,000.00

What the client paid this registrant for the period.

Client based in

California

Representation ended

Dec 31, 2025

The registrant reported terminating its work for this client.

Official filing document

Lobbyists on this filing 1

SCOTT DZIENGELSKI

Previously held: Rep. Murphy (PA-18): Leg. Dir. (2015-2017), Sr. Leg. Asst.(2013-2015), Leg. Asst. (2012-2013), Leg. Corr. (2011-2012),Staff Asst. (2010-2011); Energy and Commerce Committee:Staff (2015-2017)

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Government bodies contacted 1

HOUSE OF REPRESENTATIVES

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Bills named in this filing 1

HR 4055
Dialysis-Related Amyloidosis Treatment Act of 2025

Lobbying activity 1

Medicare/Medicaid

Advocacy in support of Medicare Coverage for Dialysis-Related Amyloidosis (DRA) Treatment. H.R. 4055 (119th Cong.).

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.